| UniProt ID | TARB1_HUMAN | |
|---|---|---|
| UniProt AC | Q13395 | |
| Protein Name | Probable methyltransferase TARBP1 | |
| Gene Name | TARBP1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 1621 | |
| Subcellular Localization | ||
| Protein Description | Probable S-adenosyl-L-methionine-dependent methyltransferase which methylates RNA molecules such as tRNAs. In case of infection by HIV-1, it binds to the loop region of TAR RNA, a region also bound by RNA polymerase II. Binding of TARBP1 and RNA polymerase II to HIV-1 TAR RNA is mutually exclusive, suggesting that TARBP1 may function alone or in conjunction with HIV-1 Tat to disengage RNA polymerase II from HIV-1 TAR RNA. May act by methylating HIV-1 TAR RNA.. | |
| Protein Sequence | MEWVLAEALLSQSRDPRALLGALCQGEASAERVETLRFLLQRLEDEEARGSGGAGALPEAAREVAAGYLVPLLRSLRGRPAGGPDPSLQPRHRRRVLRAAGAALRSCVRLAGRPQLAAALAEEALRDLLAGWRAPGAEAAVEVLAAVGPCLRPREDGPLLERVAGTAVALALGGGGDGDEAGPAEDAAALVAGRLLPVLVQCGGAALRAVWGGLAAPGASLGSGRVEEKLLVLSALAEKLLPEPGGDRARGAREAGPDARRCWRFWRTVQAGLGQADALTRKRARYLLQRAVEVSAELGADCTCGPQEGNGPSLFWWSERKKDELLKFWENYILIMETLEGNQIHVIKPVLPKLNNLFEYAVSEENGCWLFHPSWHMCIYKRMFESENKILSKEGVIHFLELYETKILPFSPEFSEFIIGPLMDALSESSLYSRSPGQPIGSCSPLGLKLQKFLVTYISLLPEEIKSSFLLKFIRKMTSRHWCAVPILFLSKALANVPRHKALGIDGLLALRDVIHCTMITHQILLRGAAQCYLLQTAMNLLDVEKVSLSDVSTFLMSLRQEESLGRGTSLWTELCDWLRVNESYFKPSPTCSSIGLHKTSLNAYVKSIVQEYVKSSAWETGENCFMPDWFEAKLVSLMVLLAVDVEGMKTQYSGKQRTENVLRIFLDPLLDVLMKFSTNAYMPLLKTDRCLQLLLKLLNTCRLKGSSAQDDEVSTVLQNFFMSTTESISEFILRRLTMNELNSVSDLDRCHLYLMVLTELINLHLKVGWKRGNPIWRVISLLKNASIQHLQEMDSGQEPTVGSQIQRVVSMAALAMVCEAIDQKPELQLDSLHAGPLESFLSSLQLNQTLQKPHAEEQSSYAHPLECSSVLEESSSSQGWGKIVAQYIHDQWVCLSFLLKKYHTLIPTTGSEILEPFLPAVQMPIRTLQSALEALTVLSSDQVLPVFHCLKVLVPKLLTSSESLCIESFDMAWKIISSLSNTQLIFWANLKAFVQFVFDNKVLTIAAKIKGQAYFKIKEIMYKIIEMSAIKTGVFNTLISYCCQSWIVSASNVSQGSLSSAKNYSELILEACIFGTVFRRDQRLVQDVQTFIENLGHDCAANIVMENTKREDHYVRICAVKFLCLLDGSNMSHKLFIEDLAIKLLDKDELVSKSKKRYYVNSLQHRVKNRVWQTLLVLFPRLDQNFLNGIIDRIFQAGFTNNQASIKYFIEWIIILILHKFPQFLPKFWDCFSYGEENLKTSICTFLAVLSHLDIITQNIPEKKLILKQALIVVLQWCFNHNFSVRLYALVALKKLWTVCKVLSVEEFDALTPVIESSLHQVESMHGAGNAKKNWQRIQEHFFFATFHPLKDYCLETIFYILPRLSGLIEDEWITIDKFTRFTDVPLAAGFQWYLSQTQLSKLKPGDWSQQDIGTNLVEADNQAEWTDVQKKIIPWNSRVSDLDLELLFQDRAARLGKSISRLIVVASLIDKPTNLGGLCRTCEVFGASVLVVGSLQCISDKQFQHLSVSAEQWLPLVEVKPPQLIDYLQQKKTEGYTIIGVEQTAKSLDLTQYCFPEKSLLLLGNEREGIPANLIQQLDVCVEIPQQGIIRSLNVHVSGALLIWEYTRQQLLSHGDTKP | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEWVLAEA -------CHHHHHHH | 40.63 | 22223895 | |
| 75 | Phosphorylation | YLVPLLRSLRGRPAG HHHHHHHHHCCCCCC | 23.53 | 22210691 | |
| 239 | Ubiquitination | VLSALAEKLLPEPGG HHHHHHHHHCCCCCC | 50.11 | - | |
| 280 | Phosphorylation | LGQADALTRKRARYL CCCHHHHHHHHHHHH | 35.55 | 20071362 | |
| 392 | Phosphorylation | ESENKILSKEGVIHF HCCCCCCCCCCCHHH | 31.94 | - | |
| 393 | Ubiquitination | SENKILSKEGVIHFL CCCCCCCCCCCHHHH | 55.85 | 29967540 | |
| 433 | Phosphorylation | LSESSLYSRSPGQPI HCCCCCCCCCCCCCC | 31.41 | 24719451 | |
| 449 | Ubiquitination | SCSPLGLKLQKFLVT CCCHHHHHHHHHHHH | 47.26 | 21963094 | |
| 452 | Ubiquitination | PLGLKLQKFLVTYIS HHHHHHHHHHHHHHH | 51.61 | 22817900 | |
| 491 | Phosphorylation | AVPILFLSKALANVP HHHHHHHHHHHHCCC | 14.46 | - | |
| 738 | Phosphorylation | EFILRRLTMNELNSV HHHHHHHCHHHCCCC | 19.01 | 23403867 | |
| 744 | Phosphorylation | LTMNELNSVSDLDRC HCHHHCCCCCCHHHH | 35.31 | 23403867 | |
| 746 | Phosphorylation | MNELNSVSDLDRCHL HHHCCCCCCHHHHHH | 32.07 | 23403867 | |
| 754 | Phosphorylation | DLDRCHLYLMVLTEL CHHHHHHHHHHHHHH | 2.97 | - | |
| 759 | Phosphorylation | HLYLMVLTELINLHL HHHHHHHHHHHHHHH | 19.82 | - | |
| 781 | Phosphorylation | NPIWRVISLLKNASI CHHHHHHHHHHHHCH | 25.45 | 24719451 | |
| 804 | Phosphorylation | GQEPTVGSQIQRVVS CCCCCHHHHHHHHHH | 21.55 | - | |
| 981 | Phosphorylation | WKIISSLSNTQLIFW HHHHHHCCCCEEEEE | 39.52 | - | |
| 983 | Phosphorylation | IISSLSNTQLIFWAN HHHHCCCCEEEEEEC | 22.75 | - | |
| 1023 | Phosphorylation | FKIKEIMYKIIEMSA EHHHHHHHHHHHHHH | 12.51 | 29083192 | |
| 1029 | Phosphorylation | MYKIIEMSAIKTGVF HHHHHHHHHHHHCHH | 17.66 | 29083192 | |
| 1122 | Acetylation | YVRICAVKFLCLLDG HHHHHHHHHHHHCCC | 17.69 | 7367025 | |
| 1144 | Ubiquitination | FIEDLAIKLLDKDEL HHHHHHHHHCCHHHH | 37.07 | 29967540 | |
| 1148 | Acetylation | LAIKLLDKDELVSKS HHHHHCCHHHHHCCC | 53.74 | 25953088 | |
| 1148 | Ubiquitination | LAIKLLDKDELVSKS HHHHHCCHHHHHCCC | 53.74 | 29967540 | |
| 1154 | Ubiquitination | DKDELVSKSKKRYYV CHHHHHCCCCHHHHH | 59.83 | 29967540 | |
| 1159 | Phosphorylation | VSKSKKRYYVNSLQH HCCCCHHHHHHHHHH | 22.20 | - | |
| 1160 | Phosphorylation | SKSKKRYYVNSLQHR CCCCHHHHHHHHHHH | 9.37 | - | |
| 1209 | Phosphorylation | NNQASIKYFIEWIII CCHHHHHHHHHHHHH | 14.23 | 25690035 | |
| 1289 | Phosphorylation | HNFSVRLYALVALKK CCHHHHHHHHHHHHH | 6.32 | 20068231 | |
| 1305 | Phosphorylation | WTVCKVLSVEEFDAL HHHHHHCCHHHHHHH | 30.39 | 29978859 | |
| 1313 | Phosphorylation | VEEFDALTPVIESSL HHHHHHHHHHHHHHH | 19.75 | 29978859 | |
| 1318 | Phosphorylation | ALTPVIESSLHQVES HHHHHHHHHHHHHHH | 27.37 | 29978859 | |
| 1319 | Phosphorylation | LTPVIESSLHQVESM HHHHHHHHHHHHHHH | 19.65 | 29978859 | |
| 1325 | Phosphorylation | SSLHQVESMHGAGNA HHHHHHHHHCCCCCH | 19.75 | 29978859 | |
| 1405 | Ubiquitination | QTQLSKLKPGDWSQQ CCCHHCCCCCCCCCC | 51.17 | 29967540 | |
| 1410 | Phosphorylation | KLKPGDWSQQDIGTN CCCCCCCCCCCCCCC | 23.78 | - | |
| 1432 | Ubiquitination | AEWTDVQKKIIPWNS CCCCCHHHHHCCCCC | 45.87 | 29967540 | |
| 1433 | Ubiquitination | EWTDVQKKIIPWNSR CCCCHHHHHCCCCCC | 28.86 | 29967540 | |
| 1442 | Phosphorylation | IPWNSRVSDLDLELL CCCCCCCCCCCHHHH | 31.20 | 17192257 | |
| 1462 | Phosphorylation | ARLGKSISRLIVVAS HHHCCCHHHHHHHHH | 28.29 | - | |
| 1473 | Acetylation | VVASLIDKPTNLGGL HHHHHCCCCCCCCHH | 46.91 | 25953088 | |
| 1475 | Phosphorylation | ASLIDKPTNLGGLCR HHHCCCCCCCCHHHH | 49.14 | - | |
| 1534 | Ubiquitination | IDYLQQKKTEGYTII HHHHHHCCCCCEEEE | 47.69 | 29967540 | |
| 1535 | Phosphorylation | DYLQQKKTEGYTIIG HHHHHCCCCCEEEEE | 41.50 | 29083192 | |
| 1538 | Phosphorylation | QQKKTEGYTIIGVEQ HHCCCCCEEEEEEEE | 6.63 | 29083192 | |
| 1539 | Phosphorylation | QKKTEGYTIIGVEQT HCCCCCEEEEEEEEC | 19.58 | 29083192 | |
| 1546 | Phosphorylation | TIIGVEQTAKSLDLT EEEEEEECCCCCCCH | 23.65 | 29083192 | |
| 1560 | Ubiquitination | TQYCFPEKSLLLLGN HHHHCCHHEEECCCC | 46.79 | - | |
| 1594 | Phosphorylation | PQQGIIRSLNVHVSG CCCCHHHHHEEECCC | 17.56 | 28509920 | |
| 1609 | Phosphorylation | ALLIWEYTRQQLLSH CCHHHHHHHHHHHHC | 15.53 | 28509920 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TARB1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TARB1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TARB1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| ASNA_HUMAN | ASNA1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1442, AND MASSSPECTROMETRY. | |